Viewing Study NCT05169905

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 3:23 AM
Ignite Modification Date: 2025-12-31 @ 5:24 PM
Study NCT ID: NCT05169905
Status: COMPLETED
Last Update Posted: 2023-04-07
First Post: 2021-12-10
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: A Study to Evaluate the Safety and Immune Response to an Unadjuvanted RSV Maternal Vaccine in Healthy Non-pregnant Females From 9 to 49 Years of Age
Sponsor: GlaxoSmithKline
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Respiratory Syncytial Virus Infections View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Respiratory Syncytial Virus Maternal vaccine View
None Combined reduced-antigen-content diphtheria, tetanus and acellular pertussis vaccine View
None Reactogenicity View
None Safety View
None Immunogenicity View
None Healthy non-pregnant girl View
None Healthy non-pregnant adult women View